Slide 1: Integral Diagnostics
Integral Diagnostics Providing Excellence in Diagnostic Imaging in Australia and New Zealand I For personal use only Macquarie Equities Conference Dr. Ian Kadish (MD & CEO) Anne Lockwood (CFO) 30 April 2019 “Good Medicine is Good Business”
Slide 2: Today's presenters
Today’s presenters For personal use only Dr. Ian Kadish Anne Lockwood Managing Director and Chief Executive Officer Chief Financial Officer Joined Integral Diagnostics in May 2017 Joined Integral Diagnostics in 2016 and appointed as Has held roles including CSC Healthcare, McKinsey and Chief F
Slide 3: Topics for discussion
Topics for discussion For personal use only 1 Company snapshot 2 Operational overview 3 Integral’s financial profile 4 Industry trends and regulatory developments 5 Integral’s Medical Leadership Model 6 Recent Expansion into New Zealand 7 Strategic update and current priorities No amendment to guida
Slide 4: Company snapshot
Company snapshot For personal use only Listed on the ASX in 2015 KEY FACTS Operates in diagnostic imaging sector which Ticker: IDX is expected to be a key beneficiary of recent campaign announcements IPO: 21 October 2015 at $1.91 per share Geographically diversified, with 52 sites Curren
Slide 5: Operational overview
Operational overview For personal use only Total IDX Geographic Victoria Queensland Western Australia New Zealand Market Core markets Ballarat, Gold Coast, South West Auckland Geelong, Toowoomba and Western Australia Warrnambool Mackay and outer western areas of Melbourne Sites (includes 27 13 9 4 5
Slide 6: Strong financial profile
Strong financial profile For personal use only Operating revenue (A$m) Operating EBITDA (A$m) Operating NPAT (A$m) 1H 2H 1H 2H 1H 2H $m $m $m 200 179.7 188.1 60 30 160.0 167.8 150 38.1 18.2 91.1 95.3 40 34.6 34.9 33.5 20 16.6 80.8 85.7 15.8 15.1 100 19.1 16.8 17.9 16.6 9.0 7.5 8.7 7.6 20 10 50 114.3
Slide 7: Industry growth rates stabilised and strong long-term drivers remain
Industry growth rates stabilised and strong long-term drivers remain For personal use only Industry growth recovering 12 month rolling growth rate by services 12 month rolling growth rate by benefits 14% -- Average 5.6% --Average 7.3% 12% 10% 8% 6% 4% 2% 0% 1: Medicare Australia Statistics Medicare
Slide 8: Regulatory environment positive
Regulatory environment positive Advanced DI modalities, MRI and PET in particular, are becoming more essential to medical diagnosis and treatment. Their importance is increasingly being recognised by government and private payers as a mechanism to improve quality of care and better manage its cost A
Slide 9: Regulatory environment positive in Australia and NZ
Regulatory environment positive in Australia and NZ Australia cont: New Zealand For personal use only Future expected changes Diagnostic Imaging announcements • No material changes as part of the Federal Election Reintroduction of MBS indexation • Annual indexation is provided for in for selected
Slide 10: Supporting Specialist and General Practice
Supporting Specialist and General Practice Hub and Spoke Model with full spectrum of comprehensive services at the hub – including PET and Nuclear Medicine, Medicare Licensed MRI’s, and specialist radiologists For personal use only 13 high acuity hospital sites, and Centres of Excellence in MSK,
Slide 11: Overview of Integral's New Zealand acquisition
Overview of Integral’s New Zealand acquisition Acquisition overview Transaction rationale For personal use only Acquired Specialist Radiology Group, Trinity MRI and High levels of radiologist training in NZ. Common Cavendish Radiology in July 2018 College accreditation with Australia Considera
Slide 12: Management's FY19 strategy – good medicine is good business
Management’s FY19 strategy – good medicine is good business For personal use only Strategy 1 Grow existing business and margin 2 Strategic acquisitions Drivers of Strategy Drive organic growth & Optimise Develop efficiency by Medical Further disciplined execution technology Centres of leveraging lea
Slide 13: 2H19 Key priorities, focus and outlook
2H19 Key priorities, focus and outlook 2H19 Key priorities, focus and outlook For personal use only Drive organic growth Selectively upgrade CT technology to meet growing demand, improve workflow and image quality, and further efficiency reduce radiation levels and cater for expanded clinical appl
Slide 14: 2H19 Key priorities, focus and outlook continued
2H19 Key priorities, focus and outlook continued 2H19 Key priorities, focus and outlook continued For personal use only Implement new Broadening of the radiologist shareholder base radiologist − FY19 Radiologist share plan oversubscribed recruitment, retention − Similar plan to be offered in FY20
Slide 15: Questions?
For personal use only Questions? 14
Slide 16: Disclaimer
Disclaimer For personal use only Some of the information contained in this presentation contains “forward-looking statements” which may not directly or exclusively relate to historical facts. These forward-looking statements reflect Integral Diagnostics Limited (IDX) current intentions, plans, expec
Slide 17: Contact us
For personal use only Contact us Investors & Media Dr Ian Kadish, CEO P: +61 3 5339 0704 E: ikadish@idxgroup.com.au